Connect with us

Palliative Sedation

CE Information
1.0 CERP credit
Completion Time
1 hour
Available Until
January 23, 2026
Ready to start this activity?
Already registered? Please log in to see your registration information.

Overview

Specialties
Acute Care, Critical Care, Hematology / Oncology, Hospice / Palliative, Mental Health, Pain Management, and Professional Development
Clinical Topics
Anxiety, Bone Cancer, Brain Cancer, Breast Cancer, Colon Cancer, Depression, Gastric Cancer, Lung Cancer, Major Depression, Mental Health, Oncology, Pain, Prostate Cancer, and Skin Cancer

This presentation is about palliative sedation as it relates to end-of-life care, respite care, and pain management. It includes discussion on implied bias from the patient, family, and healthcare provider about pain and the management of pain and when to consider palliative sedation as it pertains to terminal illness or respite therapy for intractable symptoms.   

Learning Objectives

At the end of this presentation, the participant will:

►Describe the multiple aspects and implications of suffering.

►Discuss the process of determining when Palliative Sedation is needed for control of suffering and symptoms.

►Discuss the logistics of administering Palliative Sedation, including nursing implications and pharmaceutical agents utilized.

►Anticipate ethical concerns and challenges related to Palliative Sedation.

CE Information

This activity offers 1.0 CERP credit to attendees.

Accredited by AACN.

This nursing continuing professional development activity was approved by the American Association of Critical-Care Nurses, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures

This nursing continuing professional development activity was approved by the American Association of Critical-Care Nurses, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Activity Content

Key:
Locked
Next
Complete
Failed
0% Complete
Activity Attachments

Registration to this activity includes access to the following supporting materials.

  • C60M239Presentationslides.pptx (Size: 4.96 MB)
Presentation
Duration: 43 minutes | Quality: HD
Course Evaluation
11 questions
Certificate
Access your certificate

Register For This Activity

Member

Free

Non-Member

$10.00